Literature DB >> 12187226

A retrospective review of 307 men with Peyronie's disease.

Ates Kadioglu1, Ahmet Tefekli, Bulent Erol, Tayfun Oktar, Murat Tunc, Sedat Tellaloglu.   

Abstract

PURPOSE: We discuss the clinical appearance and natural outcome of Peyronie's disease.
MATERIALS AND METHODS: During an 8-year period 307 men with Peyronie's disease were evaluated, and clinical characteristics, risk (factors), penile deformities, erectile status and outcome were analyzed.
RESULTS: Mean patient age plus or minus standard deviation was 52.8 +/- 9.3 years (range 23 to 76). Penile deformity, pain on erection and palpable nodule were the most common (85%) presenting symptoms, usually in different combinations. The remaining 15% of men (mean age 59.4 +/- 6.5 years) were not aware of the penile deformity and were diagnosed during standard evaluation for erectile dysfunction. Dorsal (45.6%) and lateral (29.3%) were the most common curvatures. The degree of deformity was less than 30 degrees in 42.7% of patients, 31 to 60 degrees in 38.8% and greater than 60 degrees in 18.6%. At least 1 risk factor for systemic vascular disease was identified in 67.5% of patients, and hypercholesterolemia and diabetes were the most common. Patients with at least 1 risk factor had a significantly higher risk for severe penile deformity. Of the men 54.4% complained of erectile dysfunction and the probability of diminished erectile capacity was 86.7% in patients older than 60 years, with Peyronie's disease for more than 12 months and at least 1 risk factor. Of 63 patients presenting with the acute phase of disease penile deformity deteriorated in 30.2%, did not change in 66.7% and resolved spontaneously in 3.2% without any treatment after a mean followup of 8.4 months.
CONCLUSIONS: Our data show that penile deformities are disabling (greater than 30 degrees) in 62.5% of cases. Risk factors, such as serum lipid abnormalities, diabetes and hypertension, seem to have significant impact on the severity of symptoms and outcome. Patients must be informed that Peyronie's disease is progressive in 30.2% without treatment and spontaneous resolution is rare.

Entities:  

Mesh:

Year:  2002        PMID: 12187226     DOI: 10.1097/01.ju.0000024040.55662.36

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  31 in total

1.  PEYRONIE'S DISEASE: A REVIEW OF ETIOLOGY, DIAGNOSIS, AND MANAGEMENT.

Authors:  Aylin N Bilgutay; Alexander W Pastuszak
Journal:  Curr Sex Health Rep       Date:  2015-06-01

Review 2.  Ultrasound in patients affected with Peyronie's disease.

Authors:  P Fornara; H-P Gerbershagen
Journal:  World J Urol       Date:  2004-07-28       Impact factor: 4.226

3.  [Assessment among German urologists of various conservative treatment modalities for Peyronie's disease. Results of a survey].

Authors:  E W Hauck; T Bschleipfer; S M Haag; V Rohde; W Weidner
Journal:  Urologe A       Date:  2005-10       Impact factor: 0.639

Review 4.  Treatment of Peyronie's disease: 2012 update.

Authors:  Ege Can Serefoglu; Wayne J G Hellstrom
Journal:  Curr Urol Rep       Date:  2011-12       Impact factor: 3.092

Review 5.  Treatment of Peyronie's disease with PDE5 inhibitors: an antifibrotic strategy.

Authors:  Nestor F Gonzalez-Cadavid; Jacob Rajfer
Journal:  Nat Rev Urol       Date:  2010-03-09       Impact factor: 14.432

6.  Long-term results of the surgical treatment of Peyronie's disease with plaque incision and grafting.

Authors:  David J Ralph
Journal:  Asian J Androl       Date:  2011-07-25       Impact factor: 3.285

Review 7.  Surgical management of Peyronie's disease.

Authors:  Uwais B Zaid; Amjad Alwaal; Xiaoyu Zhang; Tom F Lue
Journal:  Curr Urol Rep       Date:  2014-10       Impact factor: 3.092

8.  Long-term results of the surgical treatment of Peyronie's disease with Egydio's technique: a European multicentre study.

Authors:  Salvatore Sansalone; Giulio Garaffa; Rados Djinovic; Stefano Pecoraro; Mauro Silvani; Guido Barbagli; Alessandro Zucchi; Giuseppe Vespasiani; Carla Loreto
Journal:  Asian J Androl       Date:  2011-07-11       Impact factor: 3.285

9.  A novel modification of tunical plication by plaque thinning: long-term results in treating penile curvature of Peyronie's disease.

Authors:  Sentai Ding; Jiajü Lü; Hui Zhang; Lijing Wei; Kejia Ding
Journal:  Int Urol Nephrol       Date:  2009-11-24       Impact factor: 2.370

10.  The direction and severity of penile curvature does not have an impact on concomitant vasculogenic erectile dysfunction in patients with Peyronie's disease.

Authors:  E C Serefoglu; L Trost; S C Sikka; W J G Hellstrom
Journal:  Int J Impot Res       Date:  2014-07-17       Impact factor: 2.896

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.